Marimed Financial Statements From 2010 to 2025
| MRMD Stock | USD 0.11 0.01 8.33% |
Check Marimed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Marimed's main balance sheet or income statement drivers, such as , as well as many indicators such as . Marimed financial statements analysis is a perfect complement when working with Marimed Valuation or Volatility modules.
Marimed |
Marimed OTC Stock Return On Asset Analysis
Marimed's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Marimed Return On Asset | 0.0921 |
Most of Marimed's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Marimed is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Marimed has a Return On Asset of 0.0921. This is 101.05% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 165.79% lower than that of the firm.
Marimed Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Marimed's current stock value. Our valuation model uses many indicators to compare Marimed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Marimed competition to find correlations between indicators driving Marimed's intrinsic value. More Info.Marimed is regarded fifth in return on equity category among its peers. It is regarded second in return on asset category among its peers reporting about 3.04 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Marimed's earnings, one of the primary drivers of an investment's value.About Marimed Financial Statements
Marimed stakeholders use historical fundamental indicators, such as Marimed's revenue or net income, to determine how well the company is positioned to perform in the future. Although Marimed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Marimed's assets and liabilities are reflected in the revenues and expenses on Marimed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Marimed. Please read more on our technical analysis and fundamental analysis pages.
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts. Marimed operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 260 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Marimed OTC Stock
Marimed financial ratios help investors to determine whether Marimed OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marimed with respect to the benefits of owning Marimed security.